AlayaCare Raises $13.8 Million in Series B Funding Led by Inovia Capital
Toronto, August 7, 2018 – AlayaCare, the leading cloud-based software for home and community care providers, announced today a Series B investment of $13.8 million led by inovia capital. Chrysalis is joining the round, and existing investors, including Fonds Innovexport, are participating in the financing.
The financing will be used to fund AlayaCare’s continued expansion with a focus on the US market, and further investment in its proprietary technology platform. inovia capital Principal Magaly Charbonneau will join AlayaCare’s board of directors.
“We’re passionate about helping our clients deliver better patient outcomes and this funding means we can accelerate through our roadmap and evolve our product more rapidly,” said Adrian Schauer, CEO, AlayaCare. “Continuing to invest in AI, machine learning capabilities and optimization science is a priority as our increasingly robust platform means clients can lower their operating costs while improving their ability to provide care, detect adverse effects and help reduce hospital readmissions.”
“We share Adrian and AlayaCare’s vision to fundamentally improve the way home and community care services are provided by better leveraging technology,” said Charbonneau. “AlayaCare gives its clients the ability to make more informed, data-driven decisions, and its understanding of the marketplace, paired with deep client relationships, will drive continued growth and success.”
“We partner with leading entrepreneurs to build great businesses and believe Adrian and his team have the talent and sector knowledge to be a major player in homecare in the US as well as expand its client base internationally,” said Wright Steenrod, Partner, Chrysalis.
“We recognized early on that AlayaCare had all the right ingredients to become a leader in the home and community care sector,” said Serge Lavergne, Vice-President at Fonds Innovexport. “The team has exceeded all of our expectations and thus we are delighted to be further extending our support to this outstanding company.”
AlayaCare helps its clients capitalize on the shift to home-based care for the growing population of older adults in several markets globally. Home health organizations look to AlayaCare to help create capacity within their organization, and its platform provides key business insights that clients can use to increase efficiencies and better deploy resources. The software suite includes scheduling, time reporting, clinical documentation, remote patient monitoring and mobile, billing, and web apps specifically for patients, family members, and care workers.
Since its launch, AlayaCare has experienced double-digit monthly growth, expanded its operations in the US, Canada, and Australia and now employs over a 100+ staff.
AlayaCare’s unique platform includes Back Office, Client and Family Portals, Remote Patient Monitoring, Telehealth, and Mobile Care Worker functionality in one integrated and highly robust and secure cloud-based system. AlayaCare is providing the platform for Home Health Care organizations to propel their agencies towards innovation and home care of the future. AlayaCare was founded in 2014. www.alayacare.com
About inovia capital
inovia is a full-stack venture capital firm that partners with audacious founders to build enduring technology companies. We seek to transform venture capital by perfecting the craft of investing in people first. We roll up our sleeves to serve founders with dedicated mentorship, a global talent network and structured strategies for hyper-growth. Together, we rewrite the rules of old industries, push technology frontiers and pursue bold visions for a better future. inovia manages $500M across three funds, and holds offices in Montreal, Toronto, San Francisco, and London. For more information, visit www.inovia.vc.
Media Contact Information:
For AlayaCare – Amy Cole, firstname.lastname@example.org, 647-287-0025
For inovia capital – Melissa Mecca, email@example.com, 650-644-8168
For Client Enquiries:
AlayaCare Brady Murphy, VP- Sales & Marketing, 647-477-4174 ext. 201